SOLIRIS (Alexion Pharmaceuticals Inc.)


Welcome to the PulseAid listing for the SOLIRIS drug offered from Alexion Pharmaceuticals Inc.. This Complement Inhibitor [EPC],Complement Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Alexion Pharmaceuticals Inc.
NON-PROPRIETARY NAME: ECULIZUMAB
SUBSTANCE NAME: ECULIZUMAB
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Complement Inhibitor [EPC],Complement Inhibitors [MoA]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, SOLUTION, CONCENTRATE
MARKETING CATEGORY NAME: BLA
START MARKETING DATE: 2007-04-02
END MARKETING DATE: 0000-00-00


SOLIRIS HUMAN PRESCRIPTION DRUG Details:

Item DescriptionSOLIRIS from Alexion Pharmaceuticals Inc.
LABELER NAME: Alexion Pharmaceuticals Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 300(mg/30mL)
START MARKETING DATE: 2007-04-02
END MARKETING DATE: 0000-00-00
PRODUCT ID: 25682-001_0fb572bf-8c29-405e-bdc3-708e2d6d1c36
PRODUCT NDC: 25682-001
APPLICATION NUMBER: BLA125166

Other ECULIZUMAB Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Alexion Pharmaceuticals Inc.SOLIRIS